Lomitapide EU Approval Expands to Pediatric Rare Lipid Disorder
The EC label expansion targets an ultra-rare genetic LDL disorder — a reminder of how orphan-drug pipelines intersect w…
The EC label expansion targets an ultra-rare genetic LDL disorder — a reminder of how orphan-drug pipelines intersect w…
In-country fulfillment and certificate-of-analysis verification anchor the expansion as demand for research-grade pepti…
Data presented at EULAR 2026 add to the growing clinical record for targeted immunology compounds with potential nutrac…
Health systems leaning on telehealth infrastructure could accelerate practitioner-channel nutraceutical recommendations…
The PhD-founded brand's multi-channel push signals growing retailer appetite for clinically positioned collagen-infused…
A tenfold market expansion over ten years is reshaping how brands position glycemic-support ingredients and finished fo…
A new market analysis projects the leapfrogging health sector will reach $2.67 billion by 2034, with direct implication…
From antioxidant-rich spice blends to probiotic-forward sauces, operators are eyeing the $5B+ condiment category for be…
Functional News covers ingredients, clinical evidence, and formulation innovation in functional foods and nutraceutical…
Forward-Facing® Accelerated Recovery positions autonomic nervous system modulation at the center of residential addicti…
As functional oncology nutrition grows, new trial data spotlights why timely benefit enrollment matters for patients wh…
As employers expand functional wellness protocols, AI-driven impairment screening tools are entering the occupational h…